Differences between generic and branded eye drops – Dr. Andrew Meagher
In this episode, we review differences in regulatory requirements for branded and generic therapeutic agents, and how these differences can manifest in eye care. Dr. Andrew Meagher sheds light on the subject using IOP-lowering glaucoma drops as an example.
Drawing on his experience in the clinic and keen attention to scientific detail, Dr. Meagher shares knowledge as Associate Professor at the Salus University, School of Optometry.
About the guest:
Dr. Meagher received a Bachelor of Science degree in biomedical sciences with a minor in pharmacology/toxicology from SUNY Buffalo. After earning his Doctor of Optometry degree in 2015 from Salus University Pennsylvania College of Optometry, Dr. Meagher completed a Primary Care/Ocular Disease residency at The Eye Institute in 2016.
Dr. Meagher is an Assistant Professor at Salus University and is primarily involved at The Eye Institute within the Emergency & Glaucoma services. He works closely with the residents as an attending doctor and has been a mentor since he was brought on as faculty in 2016. In the Fall of 2020 he completed a two-year glaucoma fellowship under the tutelage of Dr. G. Richard Bennett and various glaucoma surgeons in the greater Philadelphia area. Dr. Meagher is also a Fellow of the American Academy of Optometry.